hit counter

Quetiapine Dosing for Depression Optimized with XGBoost Algorithm (2024 Study)

Depression is a globally pervasive mental illness that often requires complex treatment strategies. One such strategy involves the use of Quetiapine, an antipsychotic medication, as an augmentation to antidepressants. However, determining the optimal dose of Quetiapine is challenging due to individual variability. A recent study utilizes machine learning techniques to develop a predictive model for …

Read more

Polyphenols & Depression: Antidepressant Potential of Plant Compounds

Depression, a prevalent and debilitating mental health condition, affects millions worldwide. Recent studies have shown an intriguing link between dietary polyphenols, naturally occurring compounds in plant-based foods, and depression outcomes. Highlights: Prevalence of Depression: More than 300 million people globally suffer from depression, marking it as a leading cause of disability. Role of Polyphenols: Polyphenols, …

Read more

Mitophagy & Depression: Mitochondrial Autophagy as an Antidepressant Target?

Depression is a pervasive mental health issue with complex origins and often inadequate treatment options. Recent studies have suggested that mitophagy, the process of selective mitochondrial autophagy, plays a crucial role in the onset and progression of depression, offering new insights into its pathogenesis and potential treatments. Highlights: Major Depressive Disorder (MDD) affects millions globally, …

Read more

Trends in U.S. Medicaid Antidepressant Prescriptions: Newer Drugs & Higher Costs (2023 Analysis)

The U.S. Medicaid program’s spending and prescribing patterns for antidepressants between 2017 and 2021 reveal a significant shift toward newer and costlier medications. Highlights: Rising Expenditure: Medicaid’s spending on antidepressants increased from approximately $1 billion in 2017 to $1.12 billion in 2021. Preference Shift: There’s been a significant shift from older antidepressants like TCAs and …

Read more

Zembrin® (Sceletium tortuosum) for Anxiety & Depression: Testing Alkaloid-Specific Effects (2023 Study)

Sceletium tortuosum (ST) Extract, known as Zembrin®, is a traditional South African remedy was recently evaluated for its nuanced effects on anxiety and depression through a unique study using zebrafish larvae. Highlights: Zebrafish Larvae as Model Organisms: A study used zebrafish larvae to observe Zembrin®’s anxiolytic & antidepressant-like effects, offering a detailed and dynamic understanding …

Read more

Antidepressants, Bacterial Mutations, & Antibiotic Resistance?

Antibiotics have long been the cornerstone of modern medicine, but their effectiveness is increasingly threatened by the rise of antibiotic resistance. While the overuse of antibiotics is a well-acknowledged culprit, recent research reveals a surprising and relatively unexplored contributor: antidepressants. Highlights: Antidepressants and Resistance: Antidepressants, particularly those used in large quantities like SSRIs and SNRIs, …

Read more

Top Antidepressants to Quit Smoking: Bupropion & Nortriptyline (2023 Evidence Review)

In the ever-evolving fight against tobacco addiction, the potential of antidepressants, particularly bupropion and nortriptyline, as smoking cessation aids has come into sharp focus. A comprehensive review evaluated the efficacy, potential harms, and tolerability of these medications, providing insights into their role in helping smokers quit. Highlights: Bupropion significantly increases the chances of long-term smoking …

Read more